Humoral immunodeficiency
|
disease |
Immune System Diseases
|
Disease or Syndrome
|
9
|
4
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Cardiac Carcinoma
|
disease |
Neoplasms; Cardiovascular Diseases
|
Neoplastic Process
|
10
|
4
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Curling Ulcer
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
12
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Infections, Parvovirus
|
group |
Infections
|
Disease or Syndrome
|
12
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
May-Hegglin anomaly
|
phenotype |
Pathological Conditions, Signs and Symptoms; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
12
|
19
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
COLCHICINE RESISTANCE
|
phenotype |
|
Disease or Syndrome
|
13
|
3
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Diverticular Bleeding
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
13
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
ABO incompatibility
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
14
|
2
|
0.080 |
None |
1.000 |
8 |
|
2002 |
2019 |
Coccidioidomycosis
|
disease |
Infections
|
Disease or Syndrome
|
14
|
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Postthrombotic Syndrome
|
phenotype |
Cardiovascular Diseases
|
Disease or Syndrome
|
14
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Unresectable Hepatocellular Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
14
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Coagulation factor measurement
|
phenotype |
|
Laboratory Procedure
|
14
|
26
|
0.100 |
None |
1.000 |
1 |
3
|
2013 |
2013 |
Factor VIII measurement
|
phenotype |
|
Laboratory Procedure
|
15
|
42
|
0.100 |
None |
1.000 |
2 |
3
|
2010 |
2019 |
Aortitis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
15
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Hemolytic disorder
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
15
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Erythroblastosis, Fetal
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
16
|
1
|
0.030 |
None |
1.000 |
3 |
|
1979 |
2007 |
Waardenburg Syndrome Type 1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Disease or Syndrome
|
16
|
46
|
0.010 |
None |
1.000 |
1 |
|
1994 |
1994 |
Factor VII measurement
|
phenotype |
|
Laboratory Procedure
|
16
|
36
|
0.100 |
None |
1.000 |
1 |
3
|
2013 |
2013 |
Activated Partial Thromboplastin Time measurement
|
phenotype |
|
Laboratory Procedure
|
17
|
44
|
0.100 |
None |
1.000 |
3 |
3
|
2012 |
2018 |
Soluble Interleukin 6 Receptor Measurement
|
phenotype |
|
Laboratory Procedure
|
17
|
25
|
0.100 |
None |
1.000 |
2 |
2
|
2012 |
2012 |
Acute urticaria
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
17
|
|
0.010 |
None |
< 0.001 |
1 |
|
1979 |
1979 |
Infection caused by Norovirus
|
group |
Infections
|
Disease or Syndrome
|
18
|
|
0.020 |
None |
0.500 |
2 |
|
2010 |
2017 |
Acute anaemia
|
disease |
|
Disease or Syndrome
|
18
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Pigment dispersion syndrome (disorder)
|
disease |
Eye Diseases
|
Disease or Syndrome
|
18
|
3
|
0.010 |
None |
1.000 |
1 |
|
1978 |
1978 |
Rapidly progressive glomerulonephritis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
19
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |